Published in Health and Medicine Week, November 24th, 2003
Patients treated with Reminyl may also be unsupervised for more time per day compared with those taking placebo. The study appears in the peer-reviewed International Journal of Geriatric Psychiatry.
"Galantamine has been shown to have positive effects on cognition, function, global response and behavior in patients with mild-to-moderate Alzheimer disease," according to Mary Sano, PhD, director of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.